rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
1986-6-10
|
pubmed:abstractText |
In seven patients with severe atopic dermatitis (AD) we investigated the 45Ca-efflux responses from prelabelled neutrophils stimulated with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (F-Met-Leu-Phe) and catecholamines. We found no difference between the burst in 45Ca-efflux induced by F-Met-leu-Phe in AD patients when comparing with controls. Alpha 1-receptor responses are believed to be mediated by a calcium mechanism and like normal cells the 45Ca-efflux rate in AD neutrophils was unchanged both after stimulation with alpha- and beta-receptor agonists. Whereas the cAMP-hyporesponsiveness of beta-adrenergic receptors is known in atopic disease our present study might indicate a normal alpha-adrenergic response in AD neutrophils.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0365-8341
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
50-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2422859-Adolescent,
pubmed-meshheading:2422859-Adrenergic alpha-Agonists,
pubmed-meshheading:2422859-Adrenergic beta-Agonists,
pubmed-meshheading:2422859-Adult,
pubmed-meshheading:2422859-Calcium,
pubmed-meshheading:2422859-Catecholamines,
pubmed-meshheading:2422859-Dermatitis, Atopic,
pubmed-meshheading:2422859-Female,
pubmed-meshheading:2422859-Humans,
pubmed-meshheading:2422859-Ion Channels,
pubmed-meshheading:2422859-Male,
pubmed-meshheading:2422859-N-Formylmethionine Leucyl-Phenylalanine,
pubmed-meshheading:2422859-Neutrophils,
pubmed-meshheading:2422859-Receptors, Adrenergic, alpha,
pubmed-meshheading:2422859-Stimulation, Chemical
|
pubmed:year |
1985
|
pubmed:articleTitle |
Calcium efflux changes in neutrophils from patients with severe atopic dermatitis.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|